Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer
GlobeNewswire
*Saint-Herblain (France), May 21, 2024* – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today..
*Saint-Herblain (France), May 21, 2024* – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today..
*VALNEVA*
*Declaration of shares and voting rights *
*March 31,..
· Reimbursements deferred by 18 months to start in January 2026 instead of July 2024
*Saint-Herblain (France), March 18,..